Compare · head to head
Boryung vs Il Dong Pharmaceutical
Boryung ranks higher overall — 360 rank 94 vs 53.
Boryung leads on Value (66 vs 46), Quality (70 vs 58) and Safety (66 vs 47). Il Dong Pharmaceutical leads on Growth (62 vs 57). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7003850005 | KR7249420001 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 94 | 53 |
| Value | 66 | 46 |
| Quality | 70 | 58 |
| Growth | 57 | 62 |
| Safety | 66 | 47 |
| Sentiment | 43 | 39 |
| Quality details | ||
| Profitability | 70 | 74 |
| Cash Truth | 71 | 42 |
Boryung vs Bora PharmaceuticalsBoryung vs Chongkundang HoldingsBoryung vs Jeil PharmaceuticalBoryung vs Jeil PharmaAdd a third stock →
Full analyses: Boryung · Il Dong Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100